ClinicalTrials.gg

Drug

Sitneprotafib clinical trials

Also written JAB-3312.

studies test it
4
open now
2
in phase 3
1
first study started
2019

Keep track of what changes. Save the sitneprotafib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

Studies by the year they started

4 studies that test it; most in 2019 (1)

Studies that test sitneprotafib, by start year
YearStudies
20191
20201
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 4 · Other 0

Allist Pharmaceuticals, Inc. (3) · Jacobio Pharmaceuticals Co., Ltd. (1)

Often tested with

Tested in the same studies.

Glecirasib (2)

Studies

Open first, then newest update. How each study uses sitneprotafib is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 1 — sitneprotafib is usual care beside what is tested

Codes

What other systems call sitneprotafib · ClinicalTrials.gg INT017958

  • UNII (FDA) T21N67B1V3SITNEPROTAFIBOne source FDA
  • NCI Thesaurus C164218SitneprotafibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.